Become a member

Quick Registration

Full Registration Benefits -

Free Homepages for Doctors

Free Homepages for Hospitals

Free Homepages for Medical Conference

Free Homepages for NGO's

Personal Health Record Creation

Access to all Medical Slides

Access to all Jobs & Products Sale

Explore Medindia

Medindia » Press Release » PRA International Therapeutic Experts to Exhibit at BIO Europe 14th Annual International Partnering Conference

PRA International Therapeutic Experts to Exhibit at BIO Europe 14th Annual International Partnering Conference

11/15/2008 General News

RALEIGH, N.C., Nov. 14 PRA International, a leadingClinical Research Organization, will exhibit at the BIO Europe 14th AnnualInternational Partnering Conference, 17 - 19 November 2008 in Mannheim,Germany. PRA's leading scientists in the oncology and cardiovasculartherapeutic areas, as well as Business Development representatives willparticipate. PRA staff will be available for meetings throughout theconference at Booth 20 at the Congress Center Rosengarten, in Mannheim.

PRA has conducted clinical trials in more than 60 countries during itsmore than 30-year history. Operating in Europe for over 27 years, PRA hasexecuted over 1,000 studies through its 15 European offices. PRA's Europeancapabilities include:

About PRA International

PRA International is a global Clinical Research Organization providingservices through all phases of clinical development. Although we specialize inOncology, CNS, Respiratory/Allergy, Cardiovascular and Infectious Diseases, weperform studies in all therapeutic areas. PRA has supported over 2,100clinical trials through its 32 global offices. PRA's therapeutic expertise,global reach and project experience, combined with extensive local knowledge,enable our project teams to deliver consistent and on time performance for ourclients.

To learn more about PRA International, please visithttp://www.prainternational.com, email endpoints@praintl.com or call ourGlobal Headquarters at +1 (919) 786-8200.- Clinical operations staff providing coverage to 38 European countries for Phase II through Phase IV studies; - Two 70-bed Phase I units; - An innovative "virtual Phase I" model in central Europe; and - A world class bioanalytical laboratory.

SOURCE PRA International

Stem Cell Sciences Reinforces its International Patent Position in Stem Cell Technologies

InterMune to Present at Lazard Capital Markets Healthcare Conference

Comment & Contribute

* Your comment can be maximum of 2500 characters
	I agree to the terms and conditions
Your comments are automatically posted once they are submitted. All comments are however constantly reviewed for spam and irrelevant material (such as product or personal advertisements, email addresses, telephone numbers and website address). Such insertions do not conform to our policy and 'Terms of Use' and are either deleted or edited and republished. Please keep your comments brief and relevant.This section may also have questions seeking help. If you have the information you are welcome to respond, but please ensure that the information so provided is genuine and not misleading.